Endothelial differentiation of adipose-derived mesenchymal stem cells is improved by epigenetic modifying drug BIX-01294

European Journal of Cell Biology

Volumn 92, Issue 2, 2013, Pages 70-79

  Culmes, Mihaela ^a   Eckstein, Hans Henning ^a   Burgkart, Rainer ^a   Nüssler, Andreas K ^a   Guenther, Michael ^b   Wagner, Ernst ^b   Pelisek, Jaroslav ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Differentiation; Endothelial cells; Epigenetics; Mesenchymal stem cells

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD31 ANTIGEN; ENDOGLIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ABDOMINAL FAT; ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; HISTONE METHYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AZEPINES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; DNA METHYLATION; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESENCHYMAL STROMAL CELLS; OCTAMER TRANSCRIPTION FACTOR-3; QUINAZOLINES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84872495904     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.11.001     Document Type: Article

References (45)

1. Aurich H., Sgodda M., Kaltwasser P., Vetter M., Weise A., Liehr T., Brulport M., Hengstler J.G., Dollinger M.M., Fleig W.E., Christ B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009, 58:570-581.
2. Caplan A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005, 11:1198-1211.
3. Chio U.S.H., Wang M.L., Chou Y.T., Chen C.J., Hong C.F., Hsieh W.J., Chang H.T., Chen Y.S., Lin T.W., Hsu H.S., Wu C.W. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010, 70:10433-10444.
4. Colazzo F., Chester A.H., Taylor P.M., Yacoub M.H. Induction of mesenchymal to endothelial transformation of adipose-derived stem cells. J. Heart Valve Dis. 2010, 19:736-744.
5. Cross M.J., Dixelius J., Matsumoto T., Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem. Sci. 2003, 28:488-494.
6. Denis N., Kitzis A., Kruh J., Dautry F., Corcos D. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc. Oncogene 1991, 6:1453-1457.
7. Drexler HG, D.W., MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, DSMZ Catalogue of Human and Animal Cell Lines, http://www.dsmz.de/.
8. Epsztejn-Litman S., Feldman N., Abu-Remaileh M., Shufaro Y., Gerson A., Ueda J., Deplus R., Fuks F., Shinkai Y., Cedar H., Bergman Y. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol. 2008, 15:1176-1183.
9. Feldman N., Gerson A., Fang J., Li E., Zhang Y., Shinkai Y., Cedar H., Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8:188-194.
10. Feng B., Ng J.H., Heng J.C., Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009, 4:301-312.
11. Fischer L.J., McIlhenny S., Tulenko T., Golesorkhi N., Zhang P., Larson R., Lombardi J., Shapiro I., DiMuzio P.J. Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J. Surg. Res. 2009, 152:157-166.
12. Heeschen C., Chang E., Aicher A., Cooke J.P. Endothelial progenitor cells participate in nicotine-mediated angiogenesis. J. Am. Coll. Cardiol. 2006, 48:2553-2560.
13. Hong C.P., Park J., Roh T.Y. Epigenetic regulation in cell reprogramming revealed by genome-wide analysis. Epigenomics 2011, 3:73-81.
14. Huang P.P., Yang X.F., Li S.Z., Wen J.C., Zhang Y., Han Z.C. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb. Haemost. 2007, 98:1335-1342.
15. Karamysheva A.F. Mechanisms of angiogenesis. Biochemistry. Biokhimiia 2008, 73:751-762.
16. Karslioglu E., Kleinberger J.W., Salim F.G., Cox A.E., Takane K.K., Scott D.K., Stewart A.F. cMyc is a principal upstream driver of {beta}-cell proliferation in rat insulinoma cell lines and is an effective mediator of human {beta}-cell replication. Mol. Endocrinol. 2011, 25:1760-1772.
17. Konno M., Hamazaki T.S., Fukuda S., Tokuhara M., Uchiyama H., Okazawa H., Okochi H., Asashima M. Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Biochem. Biophys. Res. Commun. 2010, 400:461-465.
18. Kubicek S., O'Sullivan R.J., August E.M., Hickey E.R., Zhang Q., Teodoro M.L., Rea S., Mechtler K., Kowalski J.A., Homon C.A., Kelly T.A., Jenuwein T. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 2007, 25:473-481.
19. Li Z., Wilson K.D., Smith B., Kraft D.L., Jia F., Huang M., Xie X., Robbins R.C., Gambhir S.S., Weissman I.L., Wu J.C. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS ONE 2009, 4:e8443.
20. Li Z., Han Z., Wu J.C. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J. Cell. Biochem. 2009, 106:194-199.
21. Luckey C.J., Lu Y., Marto J.A. Understanding the first steps in embryonic stem cell exit from the pluripotent state. Transfusion (Paris) 2011, 51(Suppl. 4):118S-124S.
22. Meinhart J.G., Deutsch M., Fischlein T., Howanietz N., Froschl A., Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann. Thorac. Surg. 2001, 71:S327-S331.
23. Meng H.M., Zheng P., Wang X.Y., Liu C., Sui H.M., Wu S.J., Zhou J., Ding Y.Q., Li J.M. Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol. Ther. 2010, 9:295-302.
24. Michiels C. Endothelial cell functions. J. Cell. Physiol. 2003, 196:430-443.
25. Ochoa C.D., Wu S., Stevens T. New developments in lung endothelial heterogeneity: Von Willebrand factor. P-selectin, and the Weibel-Palade body. Semin. Thromb. Hemost. 2010, 36:301-308.
26. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., Werner C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
27. Park S., DiMaio T.A., Scheef E.A., Sorenson C.M., Sheibani N. PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. Am. J. Physiol. Cell. Physiol. 2010, 299:C1468-C1484.
28. Peroni D., Scambi I., Pasini A., Lisi V., Bifari F., Krampera M., Rigotti G., Sbarbati A., Galiè M. Stem molecular signature of adipose-derived stromal cells. Exp. Cell Res. 2007, 314:603-615.
29. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
30. Nandan M.O., Yang V.W. The role of Kruppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells. Histol. Histopathol. 2009, 24:1343-1355.
31. Ranjan A.K., Kumar U., Hardikar A.A., Poddar P., Nair P.D. Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis. PLoS ONE 2009, 4:e7718.
32. Rossant J. Stem cells and early lineage development. Cell 2008, 132:527-531.
33. Rottach A., Leonhardt H., Spada F. DNA methylation-mediated epigenetic control. J. Cell. Biochem. 2009, 108:43-51.
34. Rowland B.D., Bernards R., Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 2005, 7:1074-1082.
35. Seifalian A.M., Tiwari A., Hamilton G., Salacinski H.J. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif. Organs 2002, 26:307-320.
36. Shi Y., Desponts C., Do J.T., Hahm H.S., Scholer H.R., Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008, 3:568-574.
37. Shields J.M., Christy R.J., Yang V.W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 1996, 271:20009-20017.
38. Shimizu M., Pelisek J., Nikol S. Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree. Curr. Med. Chem. 2002, 9:1619-1630.
39. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
40. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., Gurtner G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
41. Watanabe M., Shin'oka T., Tohyama S., Hibino N., Konuma T., Matsumura G., Kosaka Y., Ishida T., Imai Y., Yamakawa M., Ikada Y., Morita S. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001, 7:429-439.
42. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., Ehrlich M., Laird P.W. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005, 33:6823-6836.
43. Yacoub M.H. The Ross operation-an evolutionary tale. Asian Cardiovasc. Thorac. Ann. 2006, 14:1-2.
44. Yang C., Zhang Z.H., Li Z.J., Yang R.C., Qian G.Q., Han Z.C. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 2004, 91:1202-1212.
45. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.